Plasma levels of atrial natriuretic peptide and endothelin-1 in experimental fat embolism

European Surgical Research

Volumn 29, Issue 2, 1997, Pages 124-132

  Rautanen, Markku ^a   Gullichsen, E ^a   Kuttila, K ^a   Nelimarkka, O ^a   Scheinin, M ^b   Leppa luoto J ^c   Niinikoski, J ^a  

^a Departments of Surgery   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c UNIVERSITY OF OULU   (Finland)

Author keywords

Animal model; Atrial natriuretic peptide; Catecholamines; Endothelin; Fat embolism; Hemodynamics; Hypoxemia pulmonary; Vascular tone; Vasoconstriction

Indexed keywords

ADRENALIN; ATRIAL NATRIURETIC FACTOR; ENDOTHELIN 1; NORADRENALIN; VASOACTIVE INTESTINAL POLYPEPTIDE;

ADRENALIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL OXYGEN TENSION; ARTICLE; BLOOD LEVEL; BONE MARROW TRANSPLANTATION; CENTRAL VENOUS PRESSURE; CONTROLLED STUDY; FAT EMBOLISM; FEMALE; HEART INDEX; HEART RATE; HEMODYNAMICS; LUNG ARTERIOVENOUS SHUNT; LUNG ARTERY PRESSURE; LUNG CAPILLARY PRESSURE; LUNG RESISTANCE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; NORADRENALIN BLOOD LEVEL; PATHOGENESIS; PRIORITY JOURNAL; SWINE;

EID: 0031040676     PISSN: 0014312X     EISSN: 14219921     Source Type: Journal    
DOI: 10.1159/000129516     Document Type: Article

References (36)

1. Gossling HR. Pellegrini VD Jr.: Fat embolism syndrome. A review of the pathophysiology and physiological basis of treatment. Clin Orthop 1982:165:68-82.
2. Gitin TA. Seidel T. Cera PJ. Glide-well OJ. Smith JL: Pulmonary mi-crovascttlar fat: The significance? Crit Care Med 1993:21:673-677.
3. Adnot S. Chabrier PE. Brun-Buis-son C: Atrial natriuretic factor attenuates the pulmonary pressor response to hypoxia. J Appl Physiol 1988.65:1975-1983.
4. DiNardo P. Peruzzi G: Physiology and pathophysiology of atrial natriuretic factor in lungs. Can J Cardiol 1992:8:503-508.
5. Hollister AS, Rodeheffer RI, White FJ, Potts JR, Imada T, Inagami T: Clearance of atrial natriuretic factor by lung, liver, and kidney in human subjects and the dog. J Clin Invest 1989:83:623-628.
6. Wakabavashi G. Ueda M. Aikawa N: Release of ANP and its physiological role in pulmonary injury due to HCI. Am J Physiol 1990:258: R690-R696.
7. Imamura T, Ohnuma N, Iwasa F, Furuya M, Havasi Y, Lnomata N, Ishihara T, Noguchi T: Protective effects of alpha-human atrial natriuretic polypeptide (alpha-h.ANP) on chemical-induced pulmonary edema. LifcSci 1988:42:403-414.
8. Ishii Y, Watanabe T, Watanabe M, Hasegawa S, Uchivama Y: Effects of atrial natriuretic peptide on type II alveolar epithelial cells of the rat lung. Autoradiographic and mor-phomctric studies. J Anat 1989:166: 85-95.
9. Baertschi AJ, Jiao JH, Carlson DE, Campbell RW, Teague WG, Willson D, Gann DS: Neural control of ANF release in hypoxia and pulmonary hypertension. Am J Physiol 1990: 28:H735-H744.
10. Simmet T. Pritze S. Thelen KI. Pes-kar PA: Release of cndothclin in the oleic acid-induced respiratory distress syndrome in rats. Eur J Pharmacol 1992:211:319-322.
11. Yanagisawa M. Kurihara H. Kimu-ra S: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988:332:411-415.
12. Lcppaluoto J. Ruskoaho H: Endo-thelin peptides: biological activities, cellular signalling and clinical significance. Ann Med 1992:24:153-161.
13. Vuolteenaho O, Koistinen P, Martikkala V, Takala T, Lcppaluoto J: Effect of physical exercise in hvpo-baric conditions on atrial natriuretic peptide secretion. Am J Physiol 1992:263:R647-R652.
14. Scheinin M, Karhuvaara S, Ojala-Karlsson P, Kallio A, Koulu M: Plasma 3,4-dihydroxyphcnylglycol (DHPG) and 3-melhoxv-4-hydroxy-phenylglycol (MHPG) are insensitive indicators of a;-adrenoceptor mediated regulation of norepinephrine release in healthy human volunteers. LifeSci 1991:49:75-84.
15. Watson AJ: Genesis of fat emboli. J Clin Pathol 1970:23:132-142.
16. Tranquilli WJ. Thurmon JC. Benson GJ: Organ blood flow and distribution of cardiac output in hypocap-nic ketamine-ancsthctized swine. Am J Vet Res 1983:44:1578-1582.
17. Wright M: Pharmacologic effects of ketamine and its use in veterinary medicine. J Am Vet Med Assoc 1982:180:1462-1471.
18. Needleman P. Greenwald JE: Atrio-peptin: A cardiac hormone intimately involved in fluid, electrolyte, and blood pressure homeostasis. N Engl J Med 1986:314:828-834.
19. Synhorst DP. Gutkowska J: Atrial distension of isolated rabbit hearts and release of atrial natriuretic factor. Am J Physiol 1988:255:R232-R236.
20. Tikkanen I. Fyhrquist F. Metsar-inne K. Leidenius R: Plasma atrial natriuretic peptide in cardiac disease and during infusion in healthy volunteers. Lancet 1985;2:66-69.
21. Baertschi AJ. Adams JM. Sullivan MP: Acute hypoxemia stimulates atrial natriuretic factor (ANF) secretion in vivo. Am J Physiol 1988:255: H295-H300.
22. Fukuda Y, Hirata Y, Yoshimi H, Kojima T, Kobayashi Y, Yanagisawa M, Masaki T: Endothclin is a potent secrctagogue for atrial natriuretic peptide in cultured rat atrial myocytes. Biochcm Biophys Res Commun 1988:155:167-172.
23. Currie MG, Newman WH: Evidence for alpha-1 adrenergic receptor regulation of atriopeptin release from the isolated rat heart. Biochcm Biophys Res Commun 1986:137: 94-100.
24. Baertschi AJ. Teague GW: Alveolar hypoxia is a powerful stimulus for ANF release in conscious lambs. Am J Physiol 1989:256:H990-H998.
25. Noll B. Hein H. Maisch B. von Wi-chert P: Changes of atrial natriuretic peptide plasma levels in patients with pulmonary embolism and obstructive lung airways disease. Pneu-mologie 1990:44:70-73.
26. Tanabe M. Ueda M. Endo M. Kita-jima M: Effect of acute lung injury and coexisting disorders on plasma concentrations of atrial natriuretic peptide. Crit Care Med 1994:22: 1762-1768.
27. Eison HB. Rosen MJ. Phillips RA. Krakoff LR: Determinants of atrial natriuretic factor in the adult respiratory distress syndrome. Chest 1988:94:1040-1045.
28. Liibbcsmeycr HJ, Woodson L, Tra-ber LD, Flynn JT, Herndon DN, Traber DL: Immunorcactivc atrial natriuretic factor is increased in ovine model of endoloxemia. Am J Physiol 1988;254:R567-R571.
29. Lang RE, Tholkcn H, Gantcn D, Luft FC, Ruskoaho H, Unger TH: Atrial natriuretic factor - a circulating hormone stimulated by volume loading. Nature 1985;314:264-266.
30. Sirvid ML. Melsarinne K. Saijon-maa O. Fyhrquist F: Tissue distribution and half-life of l2SI-endothelin in the rat: Importance of pulmonary clearance. Biochem Biophys Res Comntun 1990;167:1191-1195.
31. Druml W, Steltzer H, Waldhaus IW, Lenz K, Hammcrle A, Vierhappcr H, Gasic S, Wagner OF: Endothclin-1 in adult respiratory distress syndrome. Am Rev Respir Dis 1993: 148:1169-1173.
32. Pittet JF, Morel DR, Hcniscn A, Gunning K, Lacroix JS, Sutcr PM, Iundberg JM: Elevated plasma en-dothelin-1 concentrations arc associated with the severity of illness in patients with sepsis. Ann Surg 1991: 213:261-264.
33. Chang H. Wu GJ. Wang SM. Hung CR: Plasma endothclin level changes during hemorrhagic shock. J Trauma 1993;35:825-833.
34. Yoshizumi M. Kurihara H. Sugiya-ma T: Hemodynamic shear stress stimulates endothclin production by cultured endothelial cells. Biochcm Biophys Res Commun 1989:161: 859-864.
35. Yanagisawa M, Kurihara H, Kimu-ra S, Tomobe Y, Kobavashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988:332:411-415.
36. Yamamoto M: Pathology of experimental pulmonary bone marrow embolism. Initial lesions of the rabbit lung after intravenous infusion of allogeneic bone marrow with special reference to its pathogenesis. Pathol Jpn 1985:35:49-69.